Publication: Transmitted HIV drug resistance in Asia
1
Issued Date
2013-01-01
Resource Type
ISSN
17466318
1746630X
1746630X
Other identifier(s)
2-s2.0-84871925702
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Current Opinion in HIV and AIDS. Vol.8, No.1 (2013), 27-33
Suggested Citation
Annette H. Sohn, Padmini Srikantiah, Somnuek Sungkanuparph, Fujie Zhang Transmitted HIV drug resistance in Asia. Current Opinion in HIV and AIDS. Vol.8, No.1 (2013), 27-33. doi:10.1097/COH.0b013e32835b804f Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/31992
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Transmitted HIV drug resistance in Asia
Abstract
PURPOSE OF REVIEW: Surveillance for transmitted HIV drug resistance is essential to assessing the longer term sustainability and durability of first-line antiretroviral therapy (ART). Increases in pre-ART resistance would compromise the ability to achieve optimal and durable treatment outcomes using currently recommended antiretrovirals. RECENT FINDINGS: In the Asia region, many countries have conducted studies of transmitted resistance among recently HIV-infected and pre-ART patients. Data vary by methodology and resistance interpretation systems. Studies in some high-income settings have shown stabilizing or declining rates (e.g. Taiwan, Hong Kong), and increasing rates in others (e.g. Japan). In low-income and middle-income Asian countries, resistance has primarily been reported to be below WHO thresholds for moderate resistance (i.e. <5%). However, studies have identified an increased risk of resistance associated with male-to-male sex and/or higher rates among cohorts of MSM. Some countries still lack systematically collected transmitted resistance data. SUMMARY: To date, there does not appear to be a need for baseline resistance testing in most Asian settings for which there are data. However, MSM appear to be at higher risk of transmitted resistance and may benefit from enhanced resistance assessments and prevention interventions. © Lippincott Williams & Wilkins.